ResearcherChinese Academy of SciencesNo recent work listed

Yingying Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8224-2342; OpenAlex author ID A5088923696. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper

Papers 2

Dual Inhibitions on Glucose/Glutamine Metabolisms for Nontoxic Pancreatic Cancer Therapy. Co-author DOI 10.1021/acsami.2c00111 ↗
Efficient Gene Therapy of Pancreatic Cancer via a Peptide Nucleic Acid (PNA)-Loaded Layered Double Hydroxides (LDH) Nanoplatform. Co-author DOI 10.1002/smll.201907233 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Zhiguo Yu · 2 shared papers, 2020–2022 · strength 0.31
- Paper Dual Inhibitions on Glucose/Glutamine Metabolisms for Nontoxic Pancreatic Cancer Therapy. DOI 10.1021/acsami.2c00111 ↗
- Paper Efficient Gene Therapy of Pancreatic Cancer via a Peptide Nucleic Acid (PNA)-Loaded Layered Double Hydroxides (LDH) Nan… DOI 10.1002/smll.201907233 ↗
Jianlin Shi · 2 shared papers, 2020–2022 · strength 0.31
- Paper Dual Inhibitions on Glucose/Glutamine Metabolisms for Nontoxic Pancreatic Cancer Therapy. DOI 10.1021/acsami.2c00111 ↗
- Paper Efficient Gene Therapy of Pancreatic Cancer via a Peptide Nucleic Acid (PNA)-Loaded Layered Double Hydroxides (LDH) Nan… DOI 10.1002/smll.201907233 ↗
Dalong Ni · 1 shared paper, 2020 · strength 0.13
- Paper Efficient Gene Therapy of Pancreatic Cancer via a Peptide Nucleic Acid (PNA)-Loaded Layered Double Hydroxides (LDH) Nan… DOI 10.1002/smll.201907233 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.